Comparative Study of the Myocardium of Patients from Four COVID-19 Waves

Lubov Borisovna Mitrofanova1, Igor Aleksandrovich Makarov1, Andrey Nikolaevich Gorshkov1,2

  • 1Almazov National Medical Research Centre, St. Petersburg 197341, Russia.

Insights

This study found that cardiovascular complications like myocarditis decreased over time in COVID-19 patients. However, a direct link between SARS-CoV-2 infection and myocarditis remains unproven.

Area of Science:

  • Pathology
  • Virology
  • Cardiology

Background:

  • Limited research exists on comparing COVID-19 patients across different pandemic waves.
  • Understanding clinical and morphological changes in deceased COVID-19 patients is crucial.

Purpose of the Study:

  • To conduct a clinical and morphological analysis of patients who died from COVID-19 across four distinct waves.
  • To compare the incidence of myocardial damage and cardiovascular complications over successive COVID-19 waves.

Main Methods:

  • Autopsy myocardium samples from 276 deceased COVID-19 patients (across three waves) were histologically examined.
  • Immunohistochemistry, immunofluorescence, RT-ddPCR, and electron microscopy were employed to detect viral presence and cellular changes.
  • Analysis included markers for inflammation, endothelial damage, and viral proteins (enteroviral VP1, SARS-CoV-2 spike protein).

Main Results:

  • Active myocarditis was diagnosed in 5% of cases; 86% expressed VP1, and 22% had SARS-CoV-2 spike protein in individual cells.
  • Electron microscopy revealed potential SARS-CoV-2 virions on the endothelium of myocardial vessels.
  • Incidence of hemorrhage, myocardial necrosis, blood clots, and myocarditis significantly decreased over the waves, with CD8-T-killers appearing.

Conclusions:

  • Myocardial damage, including endotheliitis complications and myocarditis, decreased across the studied COVID-19 waves.
  • The direct causal link between SARS-CoV-2 infection and the observed myocarditis in these cases remains unproven.
  • Endotheliitis was confirmed in all immunohistochemically studied cases.
Abstract

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
13
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
13
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
12
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
25
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38